Search
Patexia Research
Case number 2:21-cv-01734

CELGENE CORPORATION v. SUN PHARMACEUTICAL INDUSTRIES, INC. et al > Summary

Court Case Number 2:21-cv-01734

Filing Date Feb 2, 2021

Termination Date Jun 22, 2021

Court New Jersey District Court

Status Judgment - Judgment on Consent

JudgesSusan D. Wigenton, Leda D. Wettre

Plaintiff

Celgene

Defendant

2

Sun Pharmaceutical Industries Ltd.

Sun Pharmaceutical Industries Inc.

Cause

35:271 Patent Infringement

Related Patents

Doc No Title Issue date
09101621 Methods for treating multiple myeloma with 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione after stem cell transplantation Aug 11, 2015
09101622 Methods for treating newly diagnosed multiple myeloma 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione in combination with dexamethasone Aug 11, 2015
08648095 Methods for treating multiple myeloma using 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione in combination with proteasome inhibitor Feb 11, 2014
08530498 Methods for treating multiple myeloma with 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)piperidine-2,6-dione Sep 10, 2013
Menu